相关实验视频

Updated: Jan 17, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

乳酸代谢检查点在免疫瘤学:机制和治疗影响

Zhe Wang¹, Ziyan Gu¹, Wendi Mo¹

¹Department of Oncology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, 210009, PR China.

|September 13, 2025

概括

在瘤微环境 (TME) 内的乳酸盐和组素乳化 (Kla) 抑制免疫反应,阻碍癌症免疫疗法. 针对这些途径提供了一个有希望的策略,以提高治疗疗效.

科学领域:

免疫学免疫学免疫学
癌症生物学癌症生物学
代谢重编程代谢重编程

背景情况:

免疫瘤学已经彻底改变了癌症治疗,但由于免疫抑制性瘤微环境 (TME) 而面临限制.
乳酸,一种代谢副产品,越来越多地被认为是它在调节TME内的免疫细胞功能中的作用.
基因组 lysine 乳糖化 (Kla) 是一种新兴的表观遗传修饰,与乳酸的免疫抑制作用有关.

研究的目的:

审查目前对乳酸代谢和基因素Kla在调节TME中的理解.
阐明乳酸和Kla损害免疫功能的机制,并促进瘤免疫逃生.
突出针对乳酸代谢的治疗策略,以加强癌症免疫治疗.

主要方法:

文献综述综合了癌症免疫学中乳酸代谢和基因素Kla的最新发现.
分析乳酸和Kla在TME内的免疫细胞重编程中的相互关联作用.
检查针对乳酸通路的治疗干预措施的临床前和临床数据.

主要成果:

通过华堡效应产生的乳酸酸会使TME酸化,并通过直接的代谢干扰来破坏免疫细胞的功能.
基因组基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因
希斯克拉显示出作为各种癌症类型的预后生物标志物的潜力.

结论:

乳酸代谢和基因素Kla是TME内的关键免疫抑制驱动因素.
针对乳酸生产及其下游表观遗传效应 (Kla) 可以克服免疫疗法耐药性.
调节乳酸代谢是一种有希望的治疗途径,可以提高癌症免疫疗法的临床疗效.

关键词:

免疫治疗是一种免疫疗法.乳酸盐是一种乳酸盐.乳母乳化乳母乳化乳母乳化瘤微环境是一个微环境.

更多相关视频

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Measuring Mitochondrial Function of Naïve and Effector CD8 T Cells

Measuring Mitochondrial Function of Naïve and Effector CD8 T Cells

Published on: March 28, 2025

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...